Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 50Colorectal Neoplasms 39Stomach Neoplasms 27Carcinoma, Hepatocellular 26Ovarian Neoplasms 25Melanoma 21Breast Neoplasms 20Carcinoma, Non-Small-Cell Lung 19Neoplasms 15Neoplasm Metastasis 15Colonic Neoplasms 14Esophageal Neoplasms 13Uterine Cervical Neoplasms 11Sarcoma 10Liver Neoplasms 10Carcinoma, Renal Cell 10Lung Neoplasms 9Anus Neoplasms 9Rectal Neoplasms 8Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Osteosarcoma 7Triple Negative Breast Neoplasms 6Mesothelioma 6Hepatoblastoma 6Gastrointestinal Neoplasms 6Carcinoma 6Adenocarcinoma 6Vaginal Neoplasms 5Small Cell Lung Carcinoma 5

Interventions

Gemcitabine 95Cisplatin 72Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 13tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Cyclophosphamide × Gastrointestinal × Clear all
NCT07614061 2026-05-29

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Shanghai Zhongshan Hospital

Phase 1 Recruiting
18 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡